Acute Myeloid Leukemia Stocks List

Related Stock Lists: Cancer Medicine Biopharmaceutical Biotechnology Solid Tumors Clinical Medicine Treatment Of Acute Myeloid Leukemia Immunology Oncology Drugs Leukemia Myelodysplastic Syndrome Acute Lymphoblastic Leukemia Antibodies Antibody Drug Conjugates Antineoplastic Drugs Autoimmune Diseases Bemcentinib Camidanlumab Tesirine Cancer Treatments

Recent Signals

Date Stock Signal Type
2020-07-02 AIKI NR7-2 Range Contraction
2020-07-02 AIKI NR7 Range Contraction
2020-07-02 AIKI Narrow Range Bar Range Contraction
2020-07-02 AIKI Calm After Storm Range Contraction
2020-07-02 AIKI Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-07-02 AIKI 1,2,3 Pullback Bullish Bullish Swing Setup
2020-07-02 APTO Bollinger Band Squeeze Range Contraction
2020-07-02 ARAV Calm After Storm Range Contraction
2020-07-02 ARAV Doji - Bullish? Reversal
2020-07-02 ARAV MACD Bearish Centerline Cross Bearish
2020-07-02 ARGX Bollinger Band Squeeze Range Contraction
2020-07-02 ATNM Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-07-02 ATNM 1,2,3 Pullback Bullish Bullish Swing Setup
2020-07-02 BEAM Doji - Bearish? Reversal
2020-07-02 BLRX 20 DMA Support Bullish
2020-07-02 BLRX Bollinger Band Squeeze Range Contraction
2020-07-02 BLRX 50 DMA Resistance Bearish
2020-07-02 CRDF Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-07-02 CRDF 1,2,3 Pullback Bullish Bullish Swing Setup
2020-07-02 CTIC Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-07-02 CTIC Crossed Above 20 DMA Bullish
2020-07-02 CTIC Hammer Candlestick Bullish
2020-07-02 CTIC 1,2,3 Pullback Bullish Bullish Swing Setup
2020-07-02 CTIC Boomer Buy Setup Bullish Swing Setup
2020-07-02 FBIO 50 DMA Support Bullish
2020-07-02 FBIO NR7 Range Contraction
2020-07-02 FBIO Bollinger Band Squeeze Range Contraction
2020-07-02 FBIO Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-07-02 GLYC Upper Bollinger Band Walk Strength
2020-07-02 MBRX 200 DMA Resistance Bearish
2020-07-02 MRUS NR7 Range Contraction
2020-07-02 MRUS Narrow Range Bar Range Contraction
2020-07-02 MRUS Bollinger Band Squeeze Range Contraction
2020-07-02 MRUS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-07-02 MRUS NR7-2 Range Contraction
2020-07-02 MRUS 20 DMA Support Bullish
2020-07-02 NK NR7 Range Contraction
2020-07-02 NK 180 Bullish Setup Bullish Swing Setup
2020-07-02 NK Stochastic Reached Overbought Strength
2020-07-02 SLS NR7 Range Contraction
2020-07-02 SLS NR7-2 Range Contraction
2020-07-02 SNSS Narrow Range Bar Range Contraction
2020-07-02 TRIL NR7 Range Contraction
2020-07-02 TRIL Bollinger Band Squeeze Range Contraction
2020-07-02 TRIL Fell Below 20 DMA Bearish

Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cells. Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection. Occasionally spread may occur to the brain, skin, or gums. As an acute leukemia, AML progresses rapidly and is typically fatal within weeks or months if left untreated.Risk factors include smoking, previous chemotherapy or radiation therapy, myelodysplastic syndrome, and exposure to the chemical benzene. The underlying mechanism involves replacement of normal bone marrow with leukemia cells, which results in a drop in red blood cells, platelets, and normal white blood cells. Diagnosis is generally based on bone marrow aspiration and specific blood tests. AML has several subtypes; for which treatments and outcomes may vary.AML, typically is initially treated with chemotherapy aimed at inducing remission. People may then go on to receive additional chemotherapy, radiation therapy, or a stem cell transplant. The specific genetic mutations present within the cancer cells may guide therapy, as well as determine how long that person is likely to survive. Arsenic trioxide may be tried in cases that have recurred following usual treatments.AML affected about one million people globally in 2015 and resulted in 147,000 deaths. It most commonly occurs in older adults. Males are affected more often than females. AML is curable in about 35% of people under 60 years old and 10% over 60 years old. Older people who are not healthy enough to receive intensive chemotherapy have a typical survival of 5–10 months. It accounts for roughly 1.8% of cancer deaths in the United States.

More about Acute Myeloid Leukemia